US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 134 actively recruiting studies with Louisiana sites out of 134 registered in total. The busiest research areas in Louisiana are Obesity, Systemic Lupus Erythematosus, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), Novartis Pharmaceuticals, Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (12), Phase 2 (27), Phase 3 (57), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
134
Recruiting Now
134
← Back to US Map
Top Conditions in Louisiana
Obesity (4)Systemic Lupus Erythematosus (3)Endometrial Cancer (3)Asthma (2)Prostate Cancer (2)Interstitial Lung Disease (2)Acute Myeloid Leukemia (2)Stroke (2)Prostatic Neoplasms, Castration-Resistant (2)Acne (2)Lung Non-Small Cell Carcinoma (2)Melanoma (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Systemic Lupus Erythematosus, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT05638581 Phase 3
Recruiting
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Condition
Wounds and Injuries
Enrollment
1,100 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT04868604 Phase 1, Phase 2
Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-e...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
54 pts
Location
United States
Sponsor
Clarity Pharmaceuticals Ltd
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06827262 N/A
Recruiting
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Condition
Chronic Low-back Pain
Enrollment
1,500 pts
Location
United States
Sponsor
Boston Scientific Corporation
View Trial →
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05848713 Phase 3
Recruiting
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquire...
Condition
Community-acquired Pneumonia
Enrollment
4,000 pts
Location
United States, Brazil, Canada
Sponsor
University of Manitoba
View Trial →
NCT06952504 Phase 3
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrol...
Condition
Endometrial Cancer
Enrollment
1,123 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07013747 Phase 1, Phase 2
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Pa...
Condition
Acne
Enrollment
228 pts
Location
United States
Sponsor
Sanofi Pasteur, a Sanofi Compa
View Trial →
NCT06411249 Phase 4
Recruiting
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Pa...
Condition
Systemic Lupus Erythematosus
Enrollment
350 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT06428643 N/A
Recruiting
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Condition
Chlamydia
Enrollment
2,322 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT07023185 N/A
Recruiting
Cold and Compression Post TKA
Condition
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
Enrollment
90 pts
Location
United States
Sponsor
Ochsner Health System
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
Page 2 of 6 — 134 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology